IRIS
GALLO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 622
NA - Nord America 271
EU - Europa 188
AF - Africa 4
OC - Oceania 3
SA - Sud America 3
Totale 1.091
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 439
US - Stati Uniti d'America 262
CN - Cina 88
IT - Italia 73
HK - Hong Kong 70
GB - Regno Unito 38
NL - Olanda 23
DE - Germania 17
CZ - Repubblica Ceca 15
IN - India 9
CA - Canada 8
TR - Turchia 5
UA - Ucraina 5
FI - Finlandia 4
FR - Francia 4
ID - Indonesia 4
AU - Australia 3
PL - Polonia 3
ZA - Sudafrica 3
AT - Austria 2
BE - Belgio 2
KR - Corea 2
KZ - Kazakistan 2
AR - Argentina 1
AZ - Azerbaigian 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
JP - Giappone 1
SA - Arabia Saudita 1
Totale 1.091
Salva come PNG Salva come JPEG
Città #
Singapore 151
Ashburn 74
Hong Kong 66
Shanghai 61
Boardman 56
Rome 41
London 32
Brno 15
Amsterdam 13
Seattle 10
San Francisco 9
Council Bluffs 8
Los Angeles 8
Pune 7
Toronto 7
Santa Clara 6
Guangzhou 4
Helsinki 4
Washington 4
Brownsville 3
Canberra 3
Warsaw 3
Buffalo 2
Central 2
Kharkiv 2
Liverpool 2
Messina 2
Munich 2
New York 2
Paris 2
Perugia 2
Vienna 2
Almere Stad 1
Budapest 1
Changchun 1
Changsha 1
Cleveland 1
Cold Lake 1
Dongguan 1
Foggia 1
Foligno 1
Frankfurt am Main 1
Genoa 1
Handan 1
Houston 1
Hyderabad 1
Jinan 1
Koekelberg 1
Nanyang 1
Pasadena 1
Pingxiang 1
Redmond 1
Rockville 1
Shenzhen 1
Siena 1
Slough 1
São Paulo 1
Tegucigalpa 1
Tokyo 1
Trieste 1
Turin 1
Wuxi 1
Xingtai 1
Xuzhou 1
Zhengzhou 1
Totale 638
Salva come PNG Salva come JPEG
Nome #
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 37
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 32
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 28
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 27
Diagnostic value of Virtual Touch Quantification (VTQ®) for differentiation of hemangiomas from malignant focal liver lesions 26
Coexistence of HBsAg and HBsAb in a difficult-to-treat chronic hepatitis B: loss of HBsAg with entecavir plus tenofovir combination 26
Combining genetic variants to improve risk prediction for nafld and its progression to cirrhosis: a proof of concept study 26
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 25
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 24
Liver toxicity in colorectal cancer patients treated with first-line FOLFIRI-containing regimen: a single institution experience 24
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 23
Hepatitis A virus in a medical setting in Madagascar: a lesson for public health 22
Lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology 21
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 21
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 20
Deep vein thrombosis, inferior vena cava interruption and multiple thrombophilic gene mutations 20
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 19
Impairment of GH/IGF-1 Axis in the liver of patients with hcv-related chronic hepatitis 19
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 19
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study 18
A challenging alfa-fetoprotein in a cirrhotic patient 18
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 18
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 18
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 17
Breath-print analysis by e-nose for classifying and monitoring chronic liver disease: a proof-of-concept study 17
Acoustic Radiation Forced Impulse of the Liver and the Spleen, Combined with Spleen Dimension and Platelet Count in New Ratio Scores, Identifies High-Risk Esophageal Varices in Well-Compensated Cirrhotic Patients 16
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis 16
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 16
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 16
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 15
Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis 15
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 15
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 15
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 15
Pain and Frailty in Hospitalized Older Adults 15
What changed in the Italian internal medicine and geriatric wards during the lockdown 15
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 14
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 14
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 14
Renal impairment and anemia during triple therapy 14
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 14
Potentially inappropriate medications, drug–drug interactions, and anticholinergic burden in elderly hospitalized patients: does an association exist with post-discharge health outcomes? 14
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 14
Telaprevir raises the plasma/whole blood ribavirin ratio: trying to come full circle on a dangerous relationship 14
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 13
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 13
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 13
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 13
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 13
Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis 13
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 12
Non-cirrhotic portal hypertension with large regenerative nodules: a diagnostic challenge 12
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 11
Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease 11
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 11
Platelet count may impact on lysosomal acid lipase activity determination in dried blood spot 11
Multimorbidity and polypharmacy in the elderly: lessons from REPOSI 11
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 10
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 10
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration 10
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 10
The PNPLA3 rs738409 C > G polymorphism is associated with the risk of progression to cirrhosis in NAFLD patients 9
Gender-differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 9
Editorial: Clinical management of older persons with sarcopenia: current status and future directions 8
Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis 8
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables 8
Steroid-refractory immune related hepatitis may hide viral re-activation 8
Need for Deprescribing in Hospital Elderly Patients Discharged with a Limited Life Expectancy: The REPOSI Study 8
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 7
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 7
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 7
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 6
Prevalence of anti-hepatitis C positivity in a nursing home: a hitherto unrecognized submerged population 6
Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study 5
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease 5
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 3
Totale 1.147
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.043
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202286 0 0 2 0 1 0 2 2 12 0 2 65
2022/202319 0 0 0 0 1 2 5 1 1 3 6 0
2023/2024162 6 13 4 22 12 71 2 6 3 4 5 14
2024/2025880 36 15 62 12 128 94 73 14 166 251 29 0
Totale 1.147